Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.

Article Details

Citation

MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG

Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.

J Med Chem. 1997 Oct 24;40(22):3501-3.

PubMed ID
9357515 [View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Binding Properties
Drug Target Property Measurement pH Temperature (°C)
苏matriptan 5-hydroxytryptamine receptor 1B IC 50 (nM) 16 N/A N/A Details
苏matriptan 5-hydroxytryptamine receptor 1B IC 50 (nM) 27 N/A N/A Details
苏matriptan 5-hydroxytryptamine receptor 1D EC 50 (nM) 16 N/A N/A Details
苏matriptan 5-hydroxytryptamine receptor 1D IC 50 (nM) 5 N/A N/A Details
苏matriptan 5-hydroxytryptamine receptor 1D IC 50 (nM) 2400 N/A N/A Details
苏matriptan 5-hydroxytryptamine receptor 1F IC 50 (nM) >1000 N/A N/A Details